Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Filings indexed 861 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
ICRA Limited has upgraded the Credit Rating as given below: Long Term- Fund Based- Term Loan- Present Rating- A- (Stable); Previous Rating- BBB (Positive) Long Term/ Short Term- Fund ....
Regulatory Filings Classification · 85% confidence The document is a formal stock exchange announcement informing investors and regulators that ICRA Limited has upgraded the company’s credit ratings. It does not contain financial statements or detailed financial report content, nor is it announcing dividends, m&a, board changes, or share issuances. It is a routine regulatory announcement that doesn’t fit any specialized category, so it falls under the Residual Regulatory Filings category (RNS).
2026-05-21 English
Credit Rating
Regulatory Filings Classification · 85% confidence The document is a stock exchange filing notifying investors of a credit rating upgrade by ICRA. It is not an actual financial report (e.g., annual or interim report), nor a dividend notice or board change. It is a general regulatory announcement to exchanges, fitting the ‘Regulatory Filings’ category (RNS).
2026-05-21 English
Monitoring Agency Report
Regulatory Filings
2026-05-04 English
Change in Management
Regulatory Filings
2026-05-04 English
Press Release
Regulatory Filings
2026-05-04 English
Outcome of Board Meeting
Regulatory Filings
2026-05-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.